Revance Logo
COMPANYPRODUCTS AND PIPELINEINVESTORSCAREERSIN THE NEWSCONTACT US
ABOUTLEADERSHIPBOARDPARTNERSHIPS
SUSTAINABILITYMEDICAL EDUCATIONAL GRANTSINVESTIGATOR SPONSORED TRIALS
Company
INVESTOR RELATIONSPRESS RELEASESEVENTS + PRESENTATIONSFINANCIALS & FILINGSCORPORATE GOVERNANCE
STOCK INFORMATIONANALYST COVERAGEINVESTOR FAQSCONTACT US
Investors
OPPORTUNITIESCULTUREBENEFITS
Careers
COMPANYPRODUCTS AND PIPELINEINVESTORSCAREERSIN THE NEWSCONTACT US
Facebook logoInstagram logoTwitter logoLinkedIn logo
1222 Demonbreun St
20th Floor
Nashville, TN 37203
+1 (510) 742-3400
LoginContact Revance
Back
October 28, 2019
Revance to Release Third Quarter 2019 Financial Results on Monday, November 4, 2019
October 23, 2019
Revance to Present Clinical Data Highlighting the Efficacy and Safety of DAXI at the ASDS 2019 Annual Meeting
October 14, 2019
Revance Appoints Mark J. Foley as President and CEO, Replacing Dan Browne
October 2, 2019
Revance Earns Great Place to Work® Certification for Second Year
September 25, 2019
Revance to Participate in the 2019 Cantor Global Healthcare Conference
September 4, 2019
Revance to Participate in the Morgan Stanley 17th Annual Global Healthcare Conference
August 28, 2019
Revance to Participate in the Wells Fargo 14th Annual Healthcare Conference
August 5, 2019
Revance Reports Second Quarter 2019 Financial Results, Provides Corporate Update
July 29, 2019
Revance to Release Second Quarter 2019 Financial Results on Monday, August 5, 2019
July 17, 2019
Revance Adds Life Sciences Audit Executive Chris Nolet to Board of Directors
Displaying 101 - 110 of 278